Slimming group wins top UK award thanks to Port Glasgow 'boy done good'
A Port Glasgow slimming group has won a prestigious UK award at a glittering ceremony.
A PORT slimming consultant has won a prestigious UK award at a glittering ceremony. International Convention Centre in Birmingham.
Joe Glancy's local group were crowned Slimming World's Group of the Year 2025 at the big bash in Birmingham - beating off competition from more than 11,500 groups and 4,000 consultants across the UK and Ireland.
The group's members, who meet every Saturday at St Mary's Episcopal Church in Port Glasgow, have lost more than 400 stone between them this year.
(Image: Slimming World UK)
(Image: Slimming World UK)
(Image: Slimming World UK) Joe, 51, said: "It is such big deal. When I heard Port Glasgow being called, I nearly died.
"And then having to make a speech to 1,000 people was very emotional.
As far as I am aware I was the first ever Scottish winner.
"A lot of Scottish consultants were there wearing their kilts and waving the Saltire. It was a great atmosphere."
Contributed
Contributed Joe, of West Woodside Avenue, is no stranger to awards, also collecting the the group's prestigious gold award for the third year running.
The dad-of-two started with 13 members, and the group now has around 250.
For more information visit https://www.slimmingworld.co.uk/become-a-consultant
Joe also enjoyed an all-expenses holidays to Athens with his wife Elaine in May as part of the nomination for Group of the Year.
He said: "I can't express how grateful I am. The trip included a trip to the Pantheon and Acropolis, Greek dancing and cooking lessons, a visit to the Olympic Stadium and the Temple of Poseidon, finished off with a cruise on the Aegean Sea with the best consultants in the company.
"To follow this up with winning UK Group of the Year against 4,000 consultants in the UK and over 7,500 groups and having to do a speech to over 1000 people - bearing in mind this is in oor wee Port - is testament to the incredible members, my friends, that come to me every Saturday morning.
"I love them all so much and am proud to help in whatever way I can."
OTHER NEWS:
Newark Trusts launches one-off grants to groups to improve premises
'Uninhabitable' Greenock flat to become holiday let after 'significant' renovation
Caring brother is scaling highest peaks in UK after his sister's battle with sepsis
The Port Glasgow Group were awarded the title based on the group's outstanding quality in a number of key areas.
This included members' incredible weight-loss success, the vibrant and inclusive atmosphere of the group, members' success from their very first week, close friendships and the consultants' ability to encourage and motivate the group.
On average, the Port Glasgow group's members average first week weight loss is over 4lbs with some members losing as much as 11 or 12 lbs in their first week.
Joe, lost 5 stone with Slimming World himself before becoming a self-employed consultant, alongside his full time job in EE, achieving his target weight after the premature passing of his dear friend.
Joe said 'I'm absolutely over the moon that we've won. Every member in our group is an absolute star as well as my friends.
"They have worked so hard to transform their own lives while cheering on and supporting their fellow members,
"Real friendships have been formed, and I am so lucky they trust me to help - especially listening to my terrible patter every Saturday morning!
'I truly believe I have the best, most rewarding, role in the world and having our incredible group recognised with this award makes it even more special."
Joe also says there is no quick fix to weight loss but that support is there for anyone who is on weight-loss medication.
Joe said: 'There's so much buzz at the moment about weight loss drugs, but the truth is there's no magic bullet when it comes to losing weight and, most importantly, keeping it off.
"It requires real change, to build long term healthy habits and understand and change your relationship with food.
"My members know that it's possible to lose weight – and maintain that weight loss – without these injections, and their incredible transformations inside and out, right from their very first week, are proof of that.
"However, we also understand the appeal of interventions like weight loss jabs when you're absolutely desperate to lose weight, so we'd never judge anyone for taking them.
"Everyone is welcome to get support at our group.
'It's the support we provide at Slimming World that sets us apart. We focus on equipping members with lifelong tools and support to lose weight and keep it off.
"With every milestone reached, you see their confidence grow and their lives change along with their clothes size."
Joe's Port Glasgow Slimming World group, which is also the biggest in the UK, takes place every Saturday, with sessions at 7.30am, 9am and 10.30am.
For more information contact Joe on 07944340609
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
Dietitian Who Lost 60 Pounds With GLP-1 Drug Reveals Foods to Avoid and Prioritize
Jennifer Lynn-Pullman is a certified specialist in obesity and weight management, so she was frustrated when her own weight kept rising over the years. 'I had struggled with my weight for a long time. My whole family struggles as well, so it's very genetic,' Lynn-Pullman, 48, a registered dietitian and manager of clinical dietetics for Vida Health, tells "And of course, in your 40s with perimenopause, it doesn't get any easier.' Lynn-Pullman, who lives in suburban Philadelphia, was alarmed when her cholesterol went up for the first time two years ago and her A1C — a measure of blood sugar — was trending up. At 5 feet, 6 inches tall, she weighed 200 pounds and worried she was on track to develop Type 2 diabetes in her 50s like her parents. Her doctor prescribed Wegovy, the version of Ozempic approved for weight loss. It's part of the GLP-1 class of medications that mimic a hormone the body produces after eating to decrease appetite and help the body manage insulin production. After starting the drug in 2023, Lynn-Pullman lost 60 pounds in 10 months and has maintained that weight for more than a year. Like many patients, she experienced side effects and had to figure out which foods to avoid on a GLP-1 and how to prevent muscle loss. Here are her tips for eating on a GLP-1 based on her own experience: Lynn-Pullman had side effects for the first six months, usually when her medication dosage was increased. GLP-1 drugs slow stomach emptying, one of the reasons patients can experience uncomfortable symptoms. Nausea and vomiting are some of the most common side effects. For nausea, Lynn-Pullman prefers to use ginger gum. She also prepares easy to digest foods like a smoothie, soup and crackers that aren't too heavy for her stomach. Vomiting is usually due to eating too much or consuming high-fat foods, so she advises eating smaller meals, not eating too fast and avoiding greasy foods. 'Fat just stays in your stomach longer,' she says. 'With someone whose stomach is emptying much slower, it causes more of an upset.' Lynn-Pullman realized her vomiting episodes were caused by high-fiber muffins she was eating to help ease constipation. Once she cut them out, the problem stopped. The dietitian decided to treat herself like her bariatric surgery patients. 'I realized that because Wegovy causes such an increased level of satiety and such a long level of fullness, that it was very similar to those patients,' she says. Lynn-Pullman eats very small frequent meals she sometimes calls 'eating episodes.' She eats a higher-protein diet to help combat any muscle loss. She has protein every time she eats, consuming that food first, then fruits and vegetables. Any starchy food is last, if there's even room for it. Since liquid fills up the stomach, she suggests not drinking beverages with meals to get enough food in, then hydrating between meals. Here's her typical daily menu: Breakfast: A protein shake, cereal with fiber and ultrafiltered milk, which contains more protein than regular milk. Lunch: A turkey sandwich or salad topped with chicken. Dinner: Chicken or salmon with a vegetable. She occasionally eats rice or pasta on the side, but it fills her up too much, so she usually skips it. Snacks: An apple with peanut butter or nuts with a piece of fruit. Lynn-Pullman always loved sweets, noting she couldn't pass up a cookie or a piece of chocolate, especially in the afternoon. But after she began using Wegovy, she stopped craving sugar. 'It was the most miraculous thing,' Lynn-Pullman recalls. 'The food noise, that inner voice saying, 'Go get something sweet' — it vanished.' Today, she occasionally eats dark chocolate or might split a dessert with her husband if she goes out to dinner, but mostly skips sweets. When it comes to alcohol, she has a drink 'once in a blue moon if she goes to a party." 'The thing that I worry about is being nauseous or even feeling dehydrated the next day,' Lynn-Pullman says. 'We usually suggest that patients refrain from it just because of all of those potential side effects.' The dietitian works out three times a week, focusing on weight training to minimize muscle loss. Three months after starting Wegovy, Lynn-Pullman noticed she was cold all the time, even in the August summer heat. She began journaling her food intake and discovered she was eating only 800 calories a day, with very little protein. 'It's easy to do on a GLP-1 because you don't feel hungry and you fill up quickly,' Lynn-Pullman says. 'We worry about malnutrition, we worry about people not getting enough nutrients.' When she started eating more protein and calories, her symptoms went away quickly. That's why it's important to work with a dietitian and report symptoms like feeling cold, tired or exhausted, or noticing hair loss — potential symptoms of eating too little, Lynn-Pullman notes. This article was originally published on
Yahoo
30 minutes ago
- Yahoo
Carrie Johnson admitted to hospital amid ‘brutal' week
Carrie Johnson, the wife of Boris Johnson, has been hospitalised with severe dehydration just weeks after giving birth. The incident prompted a stark warning from Ms Johnson about the critical importance of proper food and fluid intake for new mothers. The 37-year-old welcomed Poppy Eliza Josephine Johnson – her fourth child with the former prime minister – on 21 May. She revealed her two-night hospital stay on an Instagram story. Sharing a photo of herself cradling her newborn in hospital, she remarked that the experience was "not on my postpartum bingo card". Ms Johnson's personal ordeal comes as Britain prepares for another heatwave this weekend, with temperatures expected to exceed 30C and an amber heat health alert already in place. She wrote: 'Being hospitalised for two nights for severe dehydration was not on my postpartum bingo card.' She urged breastfeeding mothers to make sure they eat and drink enough, 'especially if your babe is clusterfeeding'. Advice on the NHS website tells new mothers to drink plenty of fluids and to have a drink beside them as the settle down to breastfeed. Water, lower fat milks, lower sugar or sugar-free drinks are all good choices, according to the NHS. Ms Johnson thanked everyone who has helped them get through a 'brutal' week. With an Amber Heat Health alert declared for the East Midlands, South East, South West, East of England and London, it's worth watching out for those who might find it difficult to cope with high temperatures. ☀️ 🌡️ Check our blog post for handy tips: — UK Health Security Agency (@UKHSA) June 27, 2025 She wrote: 'This week has honestly been brutal. 'Mastitis (me), reflux (her), dehydration (me). What a pair we are! 'But thank you for all the kind messages, especially all the brilliant advice on reflux. Really appreciate it and made me feel way less alone going thru it all. 'And as ever, thanks to our amazing NHS.' The amber heat health alert, which covers London, the East Midlands, South East, South West and East of England, came into force on Friday and will last until 6pm on Tuesday. The UK Health Security Agency (UKHSA) has also issued a yellow alert for Yorkshire and Humber and the West Midlands for the same time period, with the agency warning of significant impacts across health and social care services. The heatwave is also affecting broad parts of mainland Europe, and a Dutch tourist died of heatstroke in Mallorca, according to local reports. The 34-year-old collapsed while hiking with friends in Camí de Son Sales, the Majorca Daily Bulletin reported. Emergency services attempted to resuscitate him but were unable to, according to the publication.
Yahoo
36 minutes ago
- Yahoo
Hims & Hers' ugly split with Wegovy maker weighs on the telehealth company's future
Hims & Hers, the high-flying telehealth company that rapidly ascended from a buzzy startup selling Viagra to a multibillion-dollar business with a Super Bowl ad, had a hard week. The San Francisco company's shares took a dive Monday after its partnership with Novo Nordisk crumbled. The Danish drugmaker abruptly ended its agreement to let Hims & Hers directly sell its popular weight-loss drug, prompting the companies to spar publicly. Less than two months after agreeing to partner with Hims & Hers, Novo Nordisk accused the telehealth company of putting patient safety at risk through 'deceptive' marketing and selling a knockoff version of its drug Wegovy. Hims & Hers fired back, alleging that Novo Nordisk was "misleading the public" and wanted to 'control clinical standards and steer patients to Wegovy.' The messy split is the latest hurdle facing Hims & Hers, a platform where people subscribe to get help for hair loss, improve sex, lose weight and address other health problems. The company aims to reach $6.5 billion in revenue by 2030. The tussle also highlights the tensions between telehealth platforms and pharmaceutical companies. 'The termination of this partnership suggests that Novo still views Hims' marketing and sales tactics as a threat to branded Wegovy and indicates Novo considers Hims more of a competitor than a true partner,' Aaron DeGagne, a senior analyst of healthcare at PitchBook, said in a statement. Hims & Hers' stock price has swung wildly this year. The price had at one point soared more than 150% this year before the Novo split knocked off a nearly a third of its valuation on Monday. Its share price rose nearly 7% on Friday to end the week at $49.41. Hims & Hers is disrupting the healthcare industry, testing the limits of regulations to make it easier to buy popular drugs at lower prices. Its showdown with Novo could help define how far it can go. While Hims & Hers faces more legal risks after the breakup, some analysts said they don't expect the fallout to heavily harm the company's growth. The company is expanding beyond just treating weight loss. Still, Hims & Hers is losing a potential source of revenue. 'Even with all these revenue streams, the bigger concern (rightfully so) is the ability for these revenue streams to fill the expected hole that the end of the NovoCare partnership creates,' Michael Cherny, a senior research analyst at Leerink Partners, said in a note. NovoCare is the pharmacy people were able to access on the Hims & Hers platform to buy the weight-loss drug. Last year, Hims & Hers said in a letter to shareholders that the company expects its weight loss offerings will contribute at least $725 million of revenue in 2025 but that treatments outside of that category will make up the majority of its sales. Wegovy is just one weight-loss drug it offers. Launched in 2017, Hims initially focused on treating men's health issues such as hair loss and erectile dysfunction — concerns that people might feel too embarrassed to bring up in doctor visits. Instead, subscribers answer questions online, correspond with medical professionals virtually and get the prescribed drugs in visually pleasing packages delivered discreetly to their homes. Andrew Dudum, one of the company's co-founders and its chief executive, started Hims at venture studio Atomic in San Francisco. The startup, now known as Hims & Hers Health Inc., then expanded into women's health, went public in 2021 and grew its workforce to more than 1,600 workers. Hims & Hers' annual revenue grew from $148.8 million in 2020 to $1.48 billion in 2024. The company also became profitable with its net income reaching $126 million in 2024, compared with a loss of $18 million in 2020. The company forecasts it will reach between $2.3 billion and $2.4 billion in revenue this year. The company's growth and 2.4 million-subscriber base was turbocharged as people looked for easier access and affordable options to the wildly popular weight-loss drugs Wegovy and Ozempic. Read more: Young start-up Hims sells generic Viagra and Rogaine to the Instagram crowd Despite strong results in the first quarter of this year, the company's forecast for second-quarter revenue fell below analysts' expectations. In May, Hims & Hers said it was slashing more than 4% of its workforce after signaling it would move away from selling cheaper alternatives to weight-loss drugs. Its stock had initially surged in February after the company released a controversial Super Bowl ad promoting its treatment for weight loss. The ad marketed the telehealth platform as an affordable solution to a system that is 'built to keep us sick and stuck.' But the company's aggressive marketing triggered backlash. Doctors, politicians and drugmakers quickly criticized the company for not disclosing the risks associated with the compounded drugs that Hims & Hers sometimes uses for weight loss. With compounded drugs, licensed pharmacists alter, mix or combine ingredients of a drug to customize medicines. Though copying patented drugs is illegal, compounded knockoffs are allowed if they are tailored for a patient who might need something slightly different than what the patent-holding company produces. For example, a person might take a compounded drug if they're allergic to a certain dye. Taking compounded drugs comes with risks, according to the U.S. Food and Drug Administration. Unlike generics, they're not approved by the FDA, a federal agency that verifies whether drugs are safe and effective . Compounding drugs is also allowed when there's a shortage of an FDA-approved drug, which has happened with Wegovy and Ozempic. But those drugs are no longer in shortage, and the FDA has warned the public about taking compounded drugs when it isn't medically necessary. Read more: Cheaper alternatives to Ozempic are flooding the weight-loss market. Are they safe? The fallout between Hims & Hers and Novo Nordisk centers on its sales of compounded versions of Wegovy, a drug people inject to decrease hunger so they eat less and lose weight. In April, the two companies teamed up to make obesity treatment more affordable and accessible. Starting at $599 per month, some people were able to get prescribed to Wegovy and a Hims & Hers membership. That was much cheaper than the previous cost of paying $1,999 per month for Wegovy on the Hims & Hers platform. That partnership was short-lived. Novo Nordisk said this week that it's cutting off Hims & Hers' direct access to Wegovy. 'Hims & Hers Health, Inc. has failed to adhere to the law which prohibits mass sales of compounded drugs under the false guise of 'personalization' and are disseminating deceptive marketing that put patient safety at risk,' Novo Nordisk said in a statement. Hims & Hers advertises a compounded drug that contains the same ingredients in Wegovy for $165 per month. Novo Nordisk, citing its own investigation and a Brookings Institution report, said ingredients in knock-off drugs sold by telehealth entities and compounding pharmacies are manufactured in China and do not have FDA approval. Novo Nordisk sells Wegovy through its pharmacy NovoCare and telehealth platforms LifeMD and Ro. On Thursday, the company also announced a partnership with WeightWatchers to sell Wegovy at a discounted price in July. Dudum, Hims & Hers chief executive, said on social media site X that the telehealth provider would still provide a variety of treatments including Wegovy. The company says on its website that it works with pharmacies in Arizona and Ohio that are regulated. 'We refuse to be strong-armed by any pharmaceutical company's anticompetitive demands that infringe on the independent decision making of providers and limit patient choice,' he said in the statement. Sign up for our Wide Shot newsletter to get the latest entertainment business news, analysis and insights. This story originally appeared in Los Angeles Times. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
